Pharma Journalist -

Teva Pharmaceutical Industries announced that it has completed the divestiture of PARAGARD (intrauterine copper contraceptive) to CooperSurgical in a $1.1 billion cash transaction. This…
Read More...

Pharmaceutical Product Development, LLC (PPD) announced it was awarded a seven-year contract under the Clinical Research Support Services (CRSS) program of the Division of AIDS (DAIDS),…
Read More...

Aviragen Therapeutics and Vaxart announced that the companies have entered into a definitive merger agreement. The merger will result in a combined company, Vaxart, Inc., focused on…
Read More...

Abbott has secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its Alinity™ ci-series instruments for clinical chemistry and immunoassay diagnostics. These innovative…
Read More...

AstraZeneca and its haematology research and development centre of excellence, Acerta Pharma, announced that the US Food and Drug Administration (FDA) has granted accelerated approval…
Read More...

Medicure International has acquired an exclusive license to sell and market PREXXARTAN (valsartan) oral solution in the United States and its territories from Carmel Biosciences, Inc.…
Read More...

MilliporeSigma today announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics…
Read More...

Impel NeuroPharma announced that the first patient was dosed in the recently-initiated Phase 1 clinical trial of INP104 for acute migraine headache. INP104 is a novel dihydroergotamine…
Read More...

As the North American biotech and pharmaceutical industry continues to reflect imminent growth, SMi Group has brought a portfolio of four significant pharmaceutical conferences to the…
Read More...

The 8th in its series, Pharmaceutical Microbiology East Coast, will debut in New Jersey, November 13- 14, 2017. With only three weeks remaining, both the pharmaceutical and specialty…
Read More...